Enqi Kong1,
Chao Zhang2,
Xia Li3,
Haiping Song4,
Li Sun1,
Jing Tian5
For correspondence:- Jing Tian Email: uyl66985@126.com
Accepted: 27 April 2022 Published: 31 May 2022
Citation: Kong E, Zhang C, Li X, Song H, Sun L, Tian J. The traditional Chinese medicine (TCM), Sheng-xue-xiao-ban, inhibits the angiogenesis in ovarian cancer in vitro. Trop J Pharm Res 2022; 21(5):995-1001 doi: 10.4314/tjpr.v21i5.13
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates